ArticleFrontiers in pharmacology2025

hERG activators exhibit antitumor effects in breast cancer through calcineurin and β-catenin-mediated signaling pathways.

Yan Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.